Although conflicting studies exist [31, 40, 41], Solinas et al.’s meta-analysis, which included five prospective randomised trials, established a positive correlation between high TIL ratios and increased pCR rates in HER2 + breast cancer patients [12]. Here, ERBB2 is linked to breast carcinoma.